Detalles de la búsqueda
1.
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations.
Cancer Immunol Immunother
; 73(8): 142, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38832989
2.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother
; 73(6): 106, 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634928
3.
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
Cancer Immunol Immunother
; 72(9): 2961-2970, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248424
4.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother
; 72(11): 3665-3682, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676282
5.
A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases.
BMC Cancer
; 22(1): 415, 2022 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35428207
6.
Hematological adverse events in the management of glioblastoma.
J Neurooncol
; 156(1): 153-161, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34820776
7.
Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer.
Med Sci Monit
; 28: e938091, 2022 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36229939
8.
Prostate Adenocarcinoma with Brain Metastasis: A Surveillance, Epidemiology, and End Results Database Analysis 2010-2015.
Med Sci Monit
; 27: e930064, 2021 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33840808
9.
Disparities in prostate cancer survival in Appalachian Kentucky: a population-based study.
Rural Remote Health
; 19(2): 4989, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31078134
10.
Copper deficiency anemia: review article.
Ann Hematol
; 97(9): 1527-1534, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29959467
11.
Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Review and a Single Center Experience.
Lung
; 196(5): 577-581, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30167840
12.
Case report: Enfortumab vedotin induced refractory DKA and multi organ failure - a rare fatal adverse event.
Front Oncol
; 14: 1332478, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38425338
13.
TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
Hum Pathol
; 143: 42-49, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38052269
14.
Clinical and Genomic Features of Patients with Renal Cell Carcinoma and Advanced Chronic Kidney Disease: Analysis of a Multi-Institutional Database.
Cancers (Basel)
; 16(10)2024 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38791999
15.
Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study.
Clin Genitourin Cancer
; 22(2): 305-314.e3, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38087702
16.
Pembrolizumab in patients with advanced upper tract urothelial carcinoma: a real-world study from ARON-2 project.
Clin Exp Metastasis
; 2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38850317
17.
Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study.
Eur Urol Oncol
; 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38575409
18.
Real-World Impact of Upfront Cytoreductive Nephrectomy in Metastatic Non-Clear Cell Renal Cell Carcinoma Treated with First-Line Immunotherapy Combinations or Tyrosine Kinase Inhibitors (A Sub-Analysis from the ARON-1 Retrospective Study).
Target Oncol
; 2024 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704759
19.
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Eur Urol Oncol
; 7(1): 102-111, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481365
20.
The Role of Anticoagulation in Tumor Thrombus Associated with Renal Cell Carcinoma: A Literature Review.
Cancers (Basel)
; 15(22)2023 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38001642